And generally, discounting for free will result in more sequel sales, reviews, and
revenue than discounting to 99 cents.
Not exact matches
The provider of travel - related
discounts delivered better -
than - expected earnings and
revenue for the second quarter in its Tuesday evening report, but the bookings miss overshadowed those results.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in
revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of
discount required on Gilead's products; an increase in
discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly
discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future
revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Ms. Winston previously served from 2012 until August 2015 as Executive Vice President — Chief Financial Officer of Family Dollar Stores, Inc., a
discount retailer with more
than 8,300 stores and nearly $ 11 billion in
revenues prior to its acquisition by Dollar Tree in July 2015.
While Interactive Brokers clearly stands out from the competition as employees are able to generate an astonishing amount of
revenue — more
than $ 1,500,000 per person — we know that it's more tied to IB's
discount brokerage status and operational efficiency
than its success to digital transformation.
The most reliable measures of individual stock valuation we've found are based on formal
discounted cash flow considerations, but among publicly - available measures we've evaluated, price /
revenue ratios are better correlated with actual subsequent returns
than price / earnings ratios (though normalized profit margins and other factors are obviously necessary to make cross-sectional comparisons).
When your book is complete, every penny of
revenue is yours, forever (other
than printing costs and unavoidable retailer
discounts).
First, ebooks sold better in 2013 by numbers of total sales, but actually resulted in less overall
revenue than they have in the past; this may stem from the understanding of where ebook pricing should fall, and the fact that Amazon was able to
discount ebooks again after the stripping away of agency pricing following the DOJ lawsuit against the Big Five publishers.
Financial advisors feeling the pressure from robo - advisors and
discount brokerages to lower their fees should think again: Advisors who dropped their prices in 2017 had lower
revenue growth and took in fewer assets
than advisors who didn't lower fees, according to a PriceMetrix report cited by WealthManagement.com.
Last year Delta introduced a
revenue component to its SkyMiles program, which means that higher - paying passengers earn more miles, so the more you pay for your tickets, the more bonus miles you get (premium economy, business, and first class tickets will earn more miles
than discount economy).
The Internal
Revenue Service tends to view credit card rewards, whether cash back or frequent flyer miles or some other form of points, as a
discount rather
than income so you generally won't need to report your cash - back rewards on your tax return.
Two leading advisors to major law firms predicted a declining demand for legal services, a 15 % drop in net income from 2008, the inability to raise rates, additional layoffs, salary freezes and cost cutting, heavier fee
discounting, expenses rising faster
than revenues — and a long wait for better times.
The budget showed federal government
revenues in the coming year would be $ 3.4 billion lower
than anticipated just four months ago, reflecting the weakest two quarters of economic growth since the 2008 - 09 recession and a steep
discount on Western Canadian oil prices.